Insights On Clinical Technologies

  1. Overcoming Complex Patient Recruitment Challenges With Data 4/15/2025

    Overcome roadblocks to recruiting patients for rare disease clinical trials with RWD and RWE, including lack of diagnosis and stringent I/E criteria, geographic dispersion, and high dropout rates.

  2. Address Unmet Measurement Needs In Parkinson's Disease With Wearable DHTs 8/15/2024

    Review the latest advancements in wearable digital health technologies (DHTs) and how they are poised to address these challenges and advance treatment options for patients with movement disorders.

  3. How To Prepare Your Life Sciences Company For A Successful IPO 11/14/2024

    When you're preparing for an IPO it's important to consider transitioning to a scalable ERP system, enabling your life science company to efficiently handle financial data.

  4. How To Create Your Own Multimedia Library For Informed Consent 10/31/2024

    Implementing multimedia eConsent in clinical trials enhances participant understanding, retention, and engagement, addressing barriers in health literacy.

  5. How Partnership Ensured A Successful First Digital Trial 5/1/2024

    Discover how this collaborative approach and tailored recommendations led to the successful implementation of an eConsent tool for a kidney cancer study with U.S. Renal Care.

  6. 5 Best Practices For Getting Started With ePRO 9/16/2024

    Unlock the potential of electronic Patient Reported Outcomes (ePRO) in your clinical research by implementing these essential best practices for success.

  7. The Future Of AI In Clinical Research, Delivered Today 5/8/2025

    The FDA's new guidance outlines a future where AI models support regulatory submissions, taking a pivotal step toward modernizing regulatory science.

  8. Future Predictions For Clinical Technologies 8/11/2025

    In 2025, sponsors are prioritizing configurable, interoperable solutions that integrate seamlessly across IRT, eCOA, CTMS, eConsent, and supply chain systems.

  9. Biotech Delivers A Superior Patient And Site Experience 3/4/2025

    To become the sponsor of choice for sites and patients in congenital hyperinsulinism clinical trials, a small biotech company prioritized delivering a superior experience while streamlining operations.

  10. How AI Is Helping Transform Neurodegenerative Disease Treatment 5/23/2025

    In today’s healthcare landscape, the focus of real-world evidence has shifted from sheer database size to the quality, granularity, and actionable insights derived from detailed, de-identified patient-level data.